Clinical Study

Comparison of Goal-Directed Hemodynamic Optimization Using Pulmonary Artery Catheter and Transpulmonary Thermodilution in Combined Valve Repair: A Randomized Clinical Trial

Table 4

Clinical characteristics of the study groups.

CharacteristicTTD groupPAC group value

Crystalloids intraoperatively, mL1290 ± 2131158 ± 3270.14
Crystalloids during 24 hrs postoperatively, mL1875 ± 5311518 ± 4100.02
Colloids during 24 hrs postoperatively, mL250 ± 6875 ± 410.04
Incidence of colloid administration15%45%0.08
Fluids during 24 hrs postoperatively, mL1850 (1600–2575)1550 (1312–1700)0.01
Incidence of inotropic/vasopressor support35%65%0.11
Duration of inotropic/vasopressor support after operation, hrs 0.14
Incidence of diuretic administration30%55%0.20
Fluid balance at 24 hrs postoperatively, mL85 (−358–940)−743 (−1275–196)0.05
Diuresis at 24 hrs postoperatively, mL2410 ± 11962439 ± 9590.93
Postoperative drainage blood loss, mL557 ± 108584 ± 1900.21
SOFA score at 24 hrs postoperatively, points5 ± 16 ± 10.37
Duration of respiratory support, hrs 0.04
Length of ICU stay, hrs 0.70
Length of hospital stay, days 0.60

TTD: transpulmonary thermodilution; PAC: pulmonary artery catheter. Data are presented as %, mean ± SD or median (25th–75th percentiles).